Same Indication

Ondansetron vs Pembrolizumab

Ondansetron vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Ondansetron and Pembrolizumab.

Mechanism of Action

Ondansetron: Selective 5-HT3 receptor antagonist.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Ondansetron — 3-5 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O.

Molecular Weight: Ondansetron — 293.3660 g/mol.

Type: Ondansetron — Small molecule; Pembrolizumab — Antibody.